🔎 Trials Near Me

Home › Triple-Negative Breast Cancer › Virginia › Richmond

Triple-Negative Breast Cancer clinical trials in Richmond, VA

5 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Richmond (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

RecruitingPhase 3
  • Virginia Cancer Institute ( Site 0034), Richmond
  • Bon Secours Memorial Regional Medical Center-Oncology Research Department ( Site 0020), Midlothian · 11 mi away
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06393374

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

RecruitingPhase 3
  • Bon Secours Cancer Institute at St. Francis ( Site 0048), Midlothian · 11 mi away
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06966700

Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

RecruitingPhase 2
  • VCU Massey Comprehensive Cancer Center, Richmond
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT03606967

Triple-Negative Breast Cancer trials in other cities

Other studies in Richmond

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.